Pharmacoeconomics in Practice: QALY, ICER, and Evidence-Based Decision-Making

Pharmacoeconomics in Practice: QALY, ICER, and Evidence-Based

Decision-Making

Objectives:

•  To define key pharmacoeconomic concepts, including Quality-Adjusted Life Year (QALY) and

Incremental Cost-Effectiveness Ratio (ICER) and to understand the role of pharmacoeconomics

in healthcare systems and policy.

Date: August 14, 2025

Venue: Online Zoom 

Record is available 

Speaker: Dr. Mohammed Olaywi Alshraim

Dr. Mohammed Olaywi Alshraim holds a Doctor of Pharmacy (Pharm.D.) degree from Northern Border University, Rafha, KSA. He also earned an International Postgraduate Diploma in Pharmacoeconomics from UPF Barcelona School of Management, Spain. In addition, he completed a certificate program in Health Economics and Outcomes Research from the University of Washington, USA. Further advancing his expertise, Dr. Mohammed obtained an Executive Master’s degree in Drug Regulatory Affairs from King Saud University, KSA. With over six years of professional experience in the field of health economics, he has contributed significantly to pharmacoeconomic research and regulatory affairs in Saudi Arabia.